Heart failure in patients with recently diagnosed atrial fibrillation: findings from the GLORIA-AF Registry Phase III - Takeaways - MDSpire

Heart failure in patients with recently diagnosed atrial fibrillation: findings from the GLORIA-AF Registry Phase III

  • By

  • Bernadette Corica

  • Giulio Francesco Romiti

  • Marco Proietti

  • Giuseppe Boriani

  • Brian Olshansky

  • Menno V Huisman

  • Gregory Y H Lip

  • on behalf of the GLORIA-AF Investigators

  • September 1, 2025

  • 0 min

Share

  • 1

    Congestive heart failure (CHF) is present in 21.9% of patients recently diagnosed with atrial fibrillation (AF) in the GLORIA-AF Registry.

  • 2

    Patients with CHF and left ventricular ejection fraction (LVEF) ≤ 40% are more likely to receive oral anticoagulants compared to those with LVEF > 40%.

  • 3

    Non-vitamin K oral anticoagulants are less frequently used in patients with CHF, regardless of their left ventricular ejection fraction.

  • 4

    CHF significantly increases the risk of all-cause death and major adverse cardiovascular events in patients with AF, especially with LVEF ≤ 40%.

  • 5

    The coexistence of AF and CHF indicates a need for tailored interventions to improve patient outcomes and management strategies.

Original Source(s)

Heart failure in patients with recently diagnosed atrial fibrillation: findings from the GLORIA-AF Registry Phase III

  • by Bernadette Corica, Giulio Francesco Romiti, Marco Proietti, Giuseppe Boriani, Brian Olshansky, Menno V Huisman, Gregory Y H Lip, on behalf of the GLORIA-AF Investigators

  • September 1, 2025

Related Content

Role of psychological resilience and psychological distress in linking fear of disease progression to quality of life in chronic heart failure: a cross-sectional serial mediation analysis

Baptist Health Heart & Vascular Care Hosts ECMO Boot Camp for Clinicians

Baptist Health Heart & Vascular Care recently hosted the BHSF–UPMC ECMO Boot Camp at the Education Center at Baptist Health Baptist Hospital.

  • by

  • May 26, 2026

  • 2 min
Safety and efficacy of sacubitril/valsartan vs. benazepril administered as initial treatment for STEMI patients with mid-range ejection fraction: a propensity score matching analysis